SN
Sidharam Nagnath Chabukswar
About Sidharam Nagnath Chabukswar
Sidharam Nagnath Chabukswar has 11 years in corporate governance. Holds Director and Designated Partner roles. Currently with 1 company, including Shuttlers Healthcare Private Limited and Nagparvati Pharmacy Llp. Formerly with 2 companies, such as Wellness Life Sciences Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Nagparvati Pharmacy Llp
ABZ-3505
|
Designated Partner | 07 Dec 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Wellness Life Sciences Private Limited
U85100PN2015PTC153987
|
Director | 10 Feb 2015 | 2015 | Active |
Shuttlers Healthcare Private Limited
U85100PN2015PTC154471
|
Director | 24 Mar 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sidharam Nagnath Chabukswar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sidharam Nagnath Chabukswar
Sidharam Nagnath Chabukswar has 11 years in corporate governance. Holds Director and Designated Partner roles. Currently with 1 company, including Shuttlers Healthcare Private Limited and Nagparvati Pharmacy Llp. Formerly with 2 companies, such as Wellness Life Sciences Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Sidharam Nagnath Chabukswar is associated with 1 company as Director and Designated Partner.
Sidharam Nagnath Chabukswar has expertise in Healthcare, General Business.
Sidharam Nagnath Chabukswar has 11 years in corporate governance.